Articles Drug that lowers blood sugar also reduces blood vessel dysfunction caused by aging An FDA-approved drug medication intended to lower blood sugar may also prevent vascular constriction and stiffening in aging male mice. To find the right cure The new Roy Blunt NextGen Precision Health building is part of a larger precision health initiative. NextGen researcher profile: Christian Lorson The associate vice chancellor for research and strategic initiatives has found a logical extension from his previous research to a disease that affects several million people around the world. Fanfare for NextGen Learn about Luis Hermano Bezerra, a University of Missouri graduate student whose original composition helped celebrate the grand opening of the Roy Blunt NextGen Precision Health building. University of Missouri celebrates grand opening of the Roy Blunt NextGen Precision Health building The building anchors the NextGen initiative, which will accelerate critical health care discoveries and treatments. The art of science One Mizzou artist and faculty member created a moving tribute to her late father. That work is now at the center of the new Roy Blunt NextGen Precision Health building. NextGen researchers profile: Haval Shirwan and Esma Yolcu Husband-wife duo Haval Shirwan and Esma Yolcu are harnessing the immune system to fight disease.
